Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition
… patients who were clinically responding to treatment (top) and five patients who had progressive
disease on treatment (… The subtype of breast cancer, each patient's treatment regimen, …
disease on treatment (… The subtype of breast cancer, each patient's treatment regimen, …
The immune contexture in cancer prognosis and treatment
… , composition, functional state and organization of the leukocyte infiltrate of the tumour, can
yield information that is relevant to prognosis, prediction of a treatment response … of routine …
yield information that is relevant to prognosis, prediction of a treatment response … of routine …
Stool microbiome profiling of patients with metastatic renal cell carcinoma receiving anti–PD-1 immune checkpoint inhibitors
… the composition and diversity of the gut microbiome in patients … diversity is associated with
better treatment outcomes. … a standard-of-care nivolumab-based regimen were eligible for this …
better treatment outcomes. … a standard-of-care nivolumab-based regimen were eligible for this …
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D Falzon, E Jaramillo, HJ Schünemann, M Arentz… - 2011 - Eur Respiratory Soc
… , particularly on the optimal composition and duration of MDR-TB treatment regimens. …
to date for the Group to make recommendations on the composition of treatment regimens. …
to date for the Group to make recommendations on the composition of treatment regimens. …
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection
RM Gulick, HJ Ribaudo, CM Shikuma… - … England Journal of …, 2004 - Mass Medical Soc
… Regimens containing three nucleoside reverse-transcriptase inhibitors offer an alternative to
regimens … protease inhibitors for the initial treatment of human immunodeficiency virus type …
regimens … protease inhibitors for the initial treatment of human immunodeficiency virus type …
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
CD DiNardo, IS Tiong, A Quaglieri… - Blood, The Journal …, 2020 - ashpublications.org
… composition (%) of samples at patient … response rates achieved with venetoclax
combinations have led to widespread use of these regimens as frontline therapy in older patients …
combinations have led to widespread use of these regimens as frontline therapy in older patients …
[HTML][HTML] Body composition in patients with follicular lymphoma: asso-ciations between changes in radiomic parameters in patients treated with R-CHOP-like and RB …
F Esposito, MR Pascale, C Tesei, PE Gigliotti… - Cancers, 2023 - mdpi.com
… and R-Bendamustine are two effective treatment regimens in follicular lymphoma, this
study, together with other clinical-laboratory parameters, could help in the choice of therapy. …
study, together with other clinical-laboratory parameters, could help in the choice of therapy. …
[PDF][PDF] Rapid сommunication: key changes to treatment of multidrug-and rifampicin-resistant tuberculosis (MDR/RR-TB)
World Health Organization - 2018 - apps.who.int
… iv In this document a shorter MDR-TB regimen refers to a course of treatment for MDR/RR-TB
lasting 9 to 12 months, which is largely standardized, and whose composition and duration …
lasting 9 to 12 months, which is largely standardized, and whose composition and duration …
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS
T Zrzavy, K Rieder, V Wuketich, R Thalhammer… - Frontiers in …, 2024 - frontiersin.org
… routine clinical leukocyte phenotyping before treatment initiation could help stratify patients
according to treatment response … We found that T cell subset composition is associated with …
according to treatment response … We found that T cell subset composition is associated with …
Immune parameters affecting the efficacy of chemotherapeutic regimens
… or cytostatic response, … patients treated with conventional or targeted chemotherapies. In
this Review, we surmise that immune-relevant biomarkers may guide personalized therapeutic …
this Review, we surmise that immune-relevant biomarkers may guide personalized therapeutic …